PierFranco Conte (Pierfranco Conte)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 31

Top Venues

Cancers

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of the National Cancer Institute

Università degli Studi di Padova

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Padova Feb 01 2013

Italy

Professore di 1^ fascia :: Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche

Publications

Hesham Elghazaly, Hamdy A Azim, Hope S Rugo, David Cameron, Sandra M Swain, Curigliano Giuseppe, Nadia Harbeck, Debu Tripathy, Banu K Arun, Matti Aapro, Martine Piccart, Fatima Cardoso, Joseph Gligorov, Hagar I Elghazawy, Nagi S El Saghir, Frederique Penault-Llorca, Edith A Perez, Philip Poortmans, Hany Abdelaziz, Heba M El-Zawahry, Loay Kassem, Mohamed Sabry, Giuseppe Viale, Sana Al-Sukhun, Neven Gado, Jessica W T Leung, Lobna Ezz Elarab, Maria João Cardoso, Khaled Abdel Karim, Meteb Foheidi, Merit M Elmaadawy, PierFranco Conte, Ashraf S M Selim, Alaa Kandil, Rasha M Kamal, Ruslan M Paltuev, Valentina Guarneri, Omalkhair Abulkhair, Omar Zakaria, Mehra Golshan, Roberto Orecchia, Manal ElMahdy, Ahmed M Abdel-Aziz, Nermean Bahie Eldin
Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations. Cancer 130 (19) (2024)
PierFranco Conte, Valentina Guarneri, Roberto D'Amico
Reply to M. Kusumoto et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Hesham Elghazaly, Hamdy A Azim, Hope S Rugo, David Cameron, Sandra M Swain, Curigliano Giuseppe, Nadia Harbeck, Debu Tripathy, Banu K Arun, Matti Aapro, Martine Piccart, Fatima Cardoso, Joseph Gligorov, Hagar I Elghazawy, Nagi S El Saghir, Frederique Penault-Llorca, Edith A Perez, Philip Poortmans, Hany Abdelaziz, Heba M El-Zawahry, Loay Kassem, Mohamed Sabry, Giuseppe Viale, Sana Al-Sukhun, Neven Gado, Jessica W T Leung, Lobna Ezz Elarab, Maria João Cardoso, Khaled Abdel Karim, Meteb Foheidi, Merit M Elmaadawy, PierFranco Conte, Ashraf S M Selim, Alaa Kandil, Rasha M Kamal, Ruslan M Paltuev, Valentina Guarneri, Omalkhair Abulkhair, Omar Zakaria, Mehra Golshan, Roberto Orecchia, Manal ElMahdy, Ahmed M Abdel-Aziz, Nermean Bahie Eldin
Tailoring neo/adjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations. Cancer (2024)
PierFranco Conte, Valentina Guarneri, Roberto D'Amico
Reply to M. Kusumoto et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
PierFranco Conte, Valentina Guarneri, Roberto D'Amico
Reply to M. Kusumoto et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, Tomás Pascual, Laia Paré, Julia Maues, Patricia Galván, Maria Vittoria Dieci, Federica Miglietta, Tommaso Giarratano, Olga Martínez-Sáez, Mercedes Marín-Aguilera, Francesco Schettini, Benedetta Conte, Laura Angelats, Maria Vidal, Barbara Adamo, Montserrat Muñoz, Esther Sanfeliu, Blanca González, Ana Vivancos, Patricia Villagrasa, Joel S Parker, Charles M Perou, PierFranco Conte, Aleix Prat, Valentina Guarneri
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1. Journal of the National Cancer Institute 115 (3) (2023)
Marion T van Mackelenbergh, Sibylle Loibl, Michael Untch, Marc E Buyse, Charles E Geyer, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine J Piccart, Hervé R Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D Gelber, Coralie Poncet, Pierre Squifflet, Everardo Delforge Saad, Dominik Heinzmann, Carsten Denkert, Priya Rastogi, Javier Cortes, Valentina Guarneri, Evandro de Azambuja, David A Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ippazio Cosimo Antonazzo, Paolo Angelo Cortesi, Gerardo Miceli Sopo, Giampiero Mazzaglia, PierFranco Conte, Lorenzo Giovanni Mantovani
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis. Cancers 15 (4) (2023)
Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, Tomás Pascual, Laia Paré, Julia Maues, Patricia Galván, Maria Vittoria Dieci, Federica Miglietta, Tommaso Giarratano, Olga Martínez-Sáez, Mercedes Marín-Aguilera, Francesco Schettini, Benedetta Conte, Laura Angelats, Maria Vidal, Barbara Adamo, Montserrat Muñoz, Esther Sanfeliu, Blanca González, Ana Vivancos, Patricia Villagrasa, Joel S Parker, Charles M Perou, PierFranco Conte, Aleix Prat, Valentina Guarneri
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1. Journal of the National Cancer Institute 115 (3) (2023)
Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, Tomás Pascual, Laia Paré, Julia Maues, Patricia Galván, Maria Vittoria Dieci, Federica Miglietta, Tommaso Giarratano, Olga Martínez-Sáez, Mercedes Marín-Aguilera, Francesco Schettini, Benedetta Conte, Laura Angelats, Maria Vidal, Barbara Adamo, Montserrat Muñoz, Esther Sanfeliu, Blanca González, Ana Vivancos, Patricia Villagrasa, Joel S Parker, Charles M Perou, PierFranco Conte, Aleix Prat, Valentina Guarneri
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1. Journal of the National Cancer Institute 115 (3) (2023)
Pierre Squifflet, Everardo Delforge Saad, Sibylle Loibl, Marion T van Mackelenbergh, Michael Untch, Priya Rastogi, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine J Piccart, Hervé R Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D Gelber, Coralie Poncet, Dominik Heinzmann, Carsten Denkert, Charles E Geyer, Javier Cortes, Valentina Guarneri, Evandro de Azambuja, David A Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar, Marc E Buyse, null null
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ippazio Cosimo Antonazzo, Paolo Angelo Cortesi, Gerardo Miceli Sopo, Giampiero Mazzaglia, PierFranco Conte, Lorenzo Giovanni Mantovani
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis. Cancers 15 (4) (2023)
Ippazio Cosimo Antonazzo, Paolo Angelo Cortesi, Gerardo Miceli Sopo, Giampiero Mazzaglia, PierFranco Conte, Lorenzo Giovanni Mantovani
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis. Cancers 15 (4) (2023)
PierFranco Conte, Giancarlo Bisagni, Federico Piacentini, Samanta Sarti, Santino Minichillo, Elisa Anselmi, Michele Aieta, Vittorio Gebbia, Alessio Schirone, Antonino Musolino, Ornella Garrone, Alessandra Beano, Anita Rimanti, Francesco Giotta, Anna Turletti, Federica Miglietta, Maria Vittoria Dieci, Roberto Vicini, Sara Balduzzi, Roberto D'Amico, Valentina Guarneri
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Gaia Griguolo, Anna Tosi, Maria Vittoria Dieci, Susan Fineberg, Valentina Rossi, Annavera Ventura, Michele Bottosso, Luc Bauchet, Federica Miglietta, Jack Jacob, Valerie Rigau, Matteo Fassan, William Jacot, PierFranco Conte, Antonio Rosato, Amelie Darlix, Valentina Guarneri
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases. Neuro-oncology 24 (12) (2022)
Giulia Pasello, Martina Lorenzi, Lorenzo Calvetti, Cristina Oliani, Alberto Pavan, Adolfo Favaretto, Giovanni Palazzolo, Petros Giovanis, Fable Zustovich, Andrea Bonetti, Daniele Bernardi, Marta Mandarà, Giuseppe Aprile, Giovanna Crivellaro, Giusy Sinigaglia, Sandro Tognazzo, Paolo Morandi, Alberto Bortolami, Valentina Marino, Laura Bonanno, Valentina Guarneri, PierFranco Conte
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab. The oncologist 27 (6) (2022)
Alberto Pavan, Alessandra Ferro, Francesco Fortarezza, Marco Schiavon, Laura Evangelista, Federica Pezzuto, Francesca Lunardi, Stefano Frega, Laura Bonanno, Federico Rea, Valentina Guarneri, PierFranco Conte, Fiorella Calabrese, Giulia Pasello
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome. The oncologist 27 (2) (2022)
Alessandra Buja, Giulia Pasello, Marco Schiavon, Giuseppe De Luca, Michele Rivera, Claudia Cozzolino, Anna De Polo, Manuela Scioni, Alberto Bortolami, Vincenzo Baldo, PierFranco Conte
Cost-effectiveness analysis of the new oncological drug durvalumab in Italian patients with stage III non-small cell lung cancer. Thoracic cancer 13 (19) (2022)
Francesco Schettini, Mario Giuliano, Fabiola Giudici, Benedetta Conte, Pietro De Placido, Sergio Venturini, Carla Rognoni, Angelo Di Leo, Mariavittoria Locci, Guy Jerusalem, Lucia Del Mastro, Fabio Puglisi, PierFranco Conte, Michelino De Laurentiis, Lajos Pusztai, Mothaffar F Rimawi, Rachel Schiff, Grazia Arpino, Sabino De Placido, Aleix Prat, Daniele Generali
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis. Cancers 13 (6) (2021)
Tomás Pascual, Aranzazu Fernandez-Martinez, Maki Tanioka, Maria Vittoria Dieci, Sonia Pernas, Joaquin Gavila, Valentina Guarnieri, Javier Cortes, Patricia Villagrasa, Núria Chic, María Jesús Vidal Losada, Barbara Adamo, Montserrat Muñoz, Gaia Griguolo, Antonio Llombart, PierFranco Conte, Mafalda Oliveira, Benedetta Conte, Laia Paré, Patricia Galvan, Lisa Anne Carey, Charles M Perou, Aleix Prat
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Maria Vittoria Dieci, Valentina Guarneri, Anna Tosi, Giancarlo Bisagni, Antonino Musolino, Simon Spazzapan, Gabriella Moretti, Grazia Maria Vernaci, Gaia Griguolo, Tommaso Giarratano, Loredana Urso, Francesca Schiavi, Claudia Pinato, Giovanna Magni, Marcello Lo Mele, Gian Luca De Salvo, Antonio Rosato, PierFranco Conte
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Hesham Elghazaly, Hope S Rugo, Hamdy A Azim, Sandra M Swain, Banu Arun, Matti Aapro, Edith A Perez, Benjamin O Anderson, Frederique Penault-Llorca, PierFranco Conte, Nagi S El Saghir, Cheng-Har Yip, Marwan Ghosn, Philip M P Poortmans, Mohamed A Shehata, Armando E Giuliano, Jessica W T Leung, Valentina Guarneri, Joseph Gligorov, Bahadir M Gulluoglu, Hany Abdel Aziz, Mona Frolova, Mohamed Sabry, Charles M Balch, Roberto Orecchia, Heba M El-Zawahry, Sana A Al Sukhun, Khaled Abdel Karim, Alaa Kandil, Ruslan M Paltuev, Meteb Foheidi, Mohamed El-Shinawi, Manal ElMahdy, Omalkhair Abulkhair, Wentao Yang, Adel T Aref, Joaira Bakkach, Nermean Bahie Eldin, Hagar I Elghazawy
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer. Cancers 13 (9) (2021)
Denis Horgan, Gennaro Ciliberto, PierFranco Conte, Giuseppe Curigliano, Luis Seijo, Luis M Montuenga, Marina Garassino, Frederique Penault-Llorca, Fabrizia Galli, Isabelle L Ray-Coquard, Denis Querleu, Peter Riegman, Keith Kerr, Hein Van Poppel, Anders Bjartell, Giovanni Codacci-Pisanelli, Jasmina Koeva-Balabanova, Angelo Virgilio Paradiso, Zorana Maravic, Vassiliki Fotaki, Núria Malats, Chiara Bernini, Simonetta Buglioni, Alastair Kent, Elisabetta Munzone, Ivica Belina, Jan Van Meerbeeck, Michael J Duffy, Beata Jagielska, Ettore Capoluongo
Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine. Cancers 13 (3) (2021)
Alessandra Buja, Giulia Pasello, Giuseppe De Luca, Alberto Bortolami, Manuel Zorzi, Federico Rea, Carlo Pinato, Antonella Dal Cin, De Polo Anna, Marco Schiavon, Andrea Zuin, Marco Marchetti, Giovanna Scroccaro, Vincenzo Baldo, Massimo Rugge, Valentina Guarneri, PierFranco Conte
Non-Small-Cell Lung Cancer: Real-World Cost Consequence Analysis. JCO oncology practice 17 (8) (2021)
Patrick Neven, Stephen R D Johnston, Masakazu Toi, Joohyuk Sohn, Kenichi Inoue, Xavier Pivot, Olga Burdaeva, Meena Okera, Norikazu Masuda, Peter A Kaufman, Han Koh, Eva-Maria Grischke, PierFranco Conte, Yi Lu, Nadine Haddad, Karla C Hurt, Antonio Llombart, George W Sledge
MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR+, HER2--Advanced Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)
Alessandro Dal Maso, Martina Lorenzi, Alessandra Ferro, Sara Pilotto, Fabiana Cecere, Alessandro Follador, Valentina Polo, Alessandro Del Conte, Giulia Sartori, Marco Giavarra, Daniela Scattolin, Stefano Indraccolo, Stefano Frega, Giovanna De Maglio, Jessica Menis, Laura Bonanno, Fiorella Calabrese, Valentina Guarneri, PierFranco Conte, Giulia Pasello
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines. Future oncology (London, England) 17 (19) (2021)
Eva Maria Ciruelos, Hope S Rugo, Ingrid A Mayer, Christelle Levy, Frédéric Forget, Juan Ignacio Delgado Mingorance, Tamar Safra, Norikazu Masuda, Yeon Hee Park, Dejan Juric, PierFranco Conte, Mario Campone, Sibylle Loibl, Hiroji Iwata, Xiaolei Zhou, Jinhee Park, Antonia Ridolfi, Ines Lorenzo, Fabrice Andre
Patient-Reported Outcomes in Patients With PIK3CA-Mutated Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer From SOLAR-1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (18) (2021)
Gaia Griguolo, Fara Brasó-Maristany, Blanca González-Farré, Tomás Pascual, Núria Chic, Tamara Saurí, Ronald Kates, Oleg Gluz, Débora Martínez, Laia Paré, Vassilena Tsvetkova, David Pesantez, Maria Vidal, Barbara Adamo, Montserrat Muñoz, Patricia Galván, Laura Barberá, Miriam Cuatrecasas, Mathias Christgen, Hans Kreipe, Inés Monge-Escartín, Patricia Villagrasa, Dolors Soy, Tommaso Giarratano, Maria Vittoria Dieci, PierFranco Conte, Nadia Harbeck, Valentina Guarneri, Aleix Prat
ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer. Cancers 12 (7) (2020)
Valentina Guarneri, Maria Vittoria Dieci, Giancarlo Bisagni, Alba A Brandes, Antonio Frassoldati, Luigi Cavanna, Antonino Musolino, Francesco Giotta, Anita Rimanti, Ornella Garrone, Elena Bertone, Katia Cagossi, Oriana Nanni, Enrico Orvieto, Gaia Griguolo, Matteo Curtarello, Loredana Urso, Laia Paré, Nuria Chic, Roberto D'Amico, Aleix Prat, PierFranco Conte
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)
PierFranco Conte, Andreas Schneeweiss, Sibylle Loibl, Eleftherios P Mamounas, Gunter von Minckwitz, Max S Mano, Michael Untch, Chiun-Sheng Huang, Norman Wolmark, Priya Rastogi, Veronique D'Hondt, Andrés Redondo, Ljiljana Stamatovic, Hervé Bonnefoi, Hugo Castro-Salguero, Hans H Fischer, Tanya Wahl, Chunyan Song, Thomas Boulet, Peter Trask, Charles E Geyer
Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer. Cancer 126 (13) (2020)
Stefano Frega, Alessandro Dal Maso, Giulia Pasello, Lea Cuppari, Stefano Indraccolo, PierFranco Conte, Laura Evangelista
Novel Nuclear Medicine Imaging Applications in Immuno-Oncology. Cancers 12 (5) (2020)

PierFranco Conte.css-eqlu8i{font-size:small;padding-left:4px;} (Pierfranco Conte)

Publication Activity (10 Years)

Top Topics

Top Venues

PierFranco Conte (Pierfranco Conte)